Brief: Humacyte Announces New U.S. Department Of Defense Funding For Procurement Of Bioengineered Blood Vessels
09/02/2026 15:07
Feb 9 (Reuters) - Humacyte Inc HUMA.O: HUMACYTE ANNOUNCES NEW U.S. DEPARTMENT OF DEFENSE FUNDING FOR PROCUREMENT OF BIOENGINEERED BLOOD VESSELS HUMACYTE INC - SYMNESS IS ONLY FDA-APPROVED BIOENGINEERED BLOOD VESSEL Source text: ID:nGNX9lWbfr Further company coverage: HUMA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Humacyte
See all newsBrief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Humacyte falls after wider-than-expected quarterly loss
Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary